BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou H, Lei X, Yan Y, Lydic T, Li J, Weintraub NL, Su H, Chen W. Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy. JCI Insight 2019;5:129781. [PMID: 31185001 DOI: 10.1172/jci.insight.129781] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhou H, Xu C, Lee H, Yoon Y, Chen W. Berardinelli-Seip congenital lipodystrophy 2/SEIPIN determines brown adipose tissue maintenance and thermogenic programing. Mol Metab 2020;36:100971. [PMID: 32246911 DOI: 10.1016/j.molmet.2020.02.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wu X, Liu X, Wang H, Zhou Z, Yang C, Li Z, Zhang Y, Shi X, Zhang L, Wang Y, Xian X, Liu G, Huang W. Seipin Deficiency Accelerates Heart Failure Due to Calcium Handling Abnormalities and Endoplasmic Reticulum Stress in Mice. Front Cardiovasc Med 2021;8:644128. [PMID: 33778025 DOI: 10.3389/fcvm.2021.644128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhou H, Li J, Su H, Li J, Lydic TA, Young ME, Chen W. BSCL2/Seipin deficiency in hearts causes cardiac energy deficit and dysfunction via inducing excessive lipid catabolism. Clin Transl Med 2022;12:e736. [PMID: 35384404 DOI: 10.1002/ctm2.736] [Reference Citation Analysis]
4 Le Lay S, Magré J, Prieur X. Not Enough Fat: Mouse Models of Inherited Lipodystrophy. Front Endocrinol 2022;13:785819. [DOI: 10.3389/fendo.2022.785819] [Reference Citation Analysis]
5 Mcilroy GD, Mitchell SE, Han W, Delibegović M, Rochford JJ. Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy. Dis Model Mech 2020;13:dmm042655. [PMID: 31848133 DOI: 10.1242/dmm.042655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bruder-Nascimento T, Kress TC, Belin de Chantemele EJ. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function. F1000Res 2019;8:F1000 Faculty Rev-1756. [PMID: 31656583 DOI: 10.12688/f1000research.20150.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
7 Grabner GF, Guttenberger N, Mayer N, Migglautsch-Sulzer AK, Lembacher-Fadum C, Fawzy N, Bulfon D, Hofer P, Züllig T, Hartig L, Kulminskaya N, Chalhoub G, Schratter M, Radner FPW, Preiss-Landl K, Masser S, Lass A, Zechner R, Gruber K, Oberer M, Breinbauer R, Zimmermann R. Small-Molecule Inhibitors Targeting Lipolysis in Human Adipocytes. J Am Chem Soc 2022. [PMID: 35362954 DOI: 10.1021/jacs.1c10836] [Reference Citation Analysis]
8 Brierley GV, Semple RK. Insulin at 100 years - is rebalancing its action key to fighting obesity-related disease? Dis Model Mech 2021;14:dmm049340. [PMID: 34841432 DOI: 10.1242/dmm.049340] [Reference Citation Analysis]
9 Leggat J, Bidault G, Vidal-Puig A. Lipotoxicity: a driver of heart failure with preserved ejection fraction? Clin Sci (Lond) 2021;135:2265-83. [PMID: 34643676 DOI: 10.1042/CS20210127] [Reference Citation Analysis]